Riskpilot← Back to searchSign inGet full accessSafemed AB
ABActiveOrg 5592412935Bomgatan 5General medical practice activities · NACE 8621Est. 20201 employees
Revenue 2024
SEK 1M
+130% vs 2023
EBITDA margin
31.0%
+47% vs 2023
Equity ratio
42.4%
Financial strength
Net profit 2024
SEK 213K
-2% vs 2023
| Revenue | SEK 1M | +130% |
| EBITDA | SEK 319K | +47% |
| Net profit | SEK 213K | -2% |
| Total assets | SEK 595K | +46% |
| Equity | SEK 252K | +8% |
| Employees | 1 | — |
Legal name
Safemed AB
Org number
5592412935
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
7 februari 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget levererar konsulttjänster till både offentlig a och privata aktörer inom allmänmedicen och akutsjukvård. Jag som läkare säljer mina tjänster till landsting och privata vårdgivare.
Address
Bomgatan 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 207 | 11 | 0 | 446 | 1 027 |
| Staff expenses | — | — | −0 | −211 | −542 |
| EBITDA | 181 | −13 | −7 | 217 | 319 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 181 | −13 | −7 | 217 | 319 |
| Net financials | — | — | −0 | 0 | 6 |
| Profit before tax | 160 | −1 | −7 | 217 | 325 |
| Tax | −34 | −0 | — | — | −112 |
| Net profit | 126 | −1 | −7 | 217 | 213 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 267 | 79 | 31 | 409 | 595 |
| Equity | 151 | 25 | 17 | 234 | 252 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 96 | 47 | 6 | 167 | 335 |
| Total debt | 96 | 47 | 6 | 167 | 335 |
EBITDA margin
31.0%
This company
15.8%
Market median
+96% vs market
20202024
Equity ratio
42.4%
This company
38.2%
Market median
+11% vs market
20202024
Return on equity
84.5%
This company
18.4%
Market median
+359% vs market
20202024
Net profit margin
20.7%
This company
8.1%
Market median
+156% vs market
20202024
Asset turnover
1.73×
This company
1.12×
Market median
+54% vs market
20202024
Debt / equity
1.36×
This company
0.62×
Market median
-119% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-02-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Safemed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Shaymaa Ali Sady Sady | Deputy Board Member | 0 companies |
| Saif Hasson | Board of Directors | 0 companies |